Patent ID: 7776915

Claim:
A method of treating skin, said method comprising administering a topical composition comprising: (a) 5.0% R-lipoic acid, 2.0% acetyl-1-carnitine, 1.0% carnosine, 1.0% astaxanthin, 0.5% tocotrienol, 0.5% tocopherol, 1.0% sesame oil, 0.5% grape proanthocyanidin, and 0.05% E.D.T.A. (ethylenediamine tetracetic acid); (b) 1.0% R-lipoic acid, 1.0% acetyl-1-carnitine, 1.0% carnosine, 0.2% Benfotiamine, 1.0% bilberry anthocyanin, 0.5% rosmarinic acid, 1.0% shark derived glycosaminoglycan, and 0.5% tocopherol; (c) 1.0% R-dihydrolipoic acid, 2.0% acetyl-1-carnitine, 1.0% carnosine, 0.5% lutein, 3.0% tetrahexyldecylascorbate, 0.5% lycopene, 0.1% coenzyme Q10 (ubiquinone), and 0.5% curcumine; (d) 1.0% R-lipoic acid, 1.0% R-dihydrolipoic acid, 1.0% acetyl-1-carnitine, 3.0% carnosine, and 1.0% NADH; (e) 1.0% R-dihydrolipoic acid, 1.0% acetyl-1-carnitine, 3.0% carnosine, 1.0% dipalmitoyl-hydroxy-proline, and 1.0% wolfberry extract; (f) 2.0% R-lipoic acid, 2.0% 1-carnitine, 2.0% 1-carnosine, 1.0% 1-glutathione, 2.0% bilberry anthocyanin, 1.0% rosemary extract, and 1.0% myristicin; or (g) 1.0% R-lipoic acid, 2.0% 1-carnitine, 2.0% 1-carnosine, 0.5% Huperzine-A, and 1.0% polyenylphosphatidylcholine; and a dermatologically acceptable carrier; wherein amounts are in weight percent and said composition is effective in the treatment of skin.